Eric Adams

Track

Insider profile

Currently holds a position at InMed Pharmaceuticals Inc

Performance

Overall performance
1.6
Performance over holding periods
1.6
30 days 90 days 120 days
Average return -7% 8.2% 15.1%
Success rate 27% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
President, Chief Executive Officer, Director InMed Pharmaceuticals Inc June 16, 2016 -
Eric Adams's trades of InMed Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
399.46
Quantity 96,316 +27.2%
Value US$4,453,937
Transaction date
Purchase
Price
56.46
Quantity 2,935 +3.1%
Value US$3,748,721
Transaction date
Purchase
Price
376.86
Quantity 39,425 -5.5%
Value US$2,004,122
Transaction date
Purchase
Price
1.75
Quantity 11,400 +70.9%
Value US$19,984
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-02-21 2024-02-20
B Purchase
96,316 +27.2%
399.46
US$4,453,937 		96,316 +27.2% 399.46 US$4,453,937
2022-04-18 2022-04-14
B Purchase
2,935 +3.1%
56.46
US$3,748,721 		2,935 +3.1% 56.46 US$3,748,721
2022-04-13 2022-04-13
B Purchase
39,425 -5.5%
376.86
US$2,004,122 		39,425 -5.5% 376.86 US$2,004,122
2021-09-29 2021-09-28
B Purchase
11,400 +70.9%
1.75
US$19,984 		11,400 +70.9% 1.75 US$19,984